{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:39:00Z","timestamp":1787564340060,"version":"build-2736575974"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T00:00:00Z","timestamp":1735084800000},"content-version":"vor","delay-in-days":146,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.prp.2024.155465","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T06:21:34Z","timestamp":1720938094000},"page":"155465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Fatty acid synthase: A key driver of ovarian cancer metastasis and a promising therapeutic target"],"prefix":"10.1016","volume":"260","author":[{"given":"Nuha","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safwan","family":"Moton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Kuttikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirti S.","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Masoodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarfraz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahab","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prp.2024.155465_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3-4","key":"10.1016\/j.prp.2024.155465_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10555-012-9371-y","article-title":"Using MKK4's metastasis suppressor function to identify and dissect cancer cell-microenvironment interactions during metastatic colonization","volume":"31","author":"Krishnan","year":"2012","journal-title":"Cancer Metastas\u00a0Rev."},{"issue":"2","key":"10.1016\/j.prp.2024.155465_bib3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ygyno.2020.05.002","article-title":"Ovarian cancer symptoms, routes to diagnosis and survival - population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)","volume":"158","author":"Dilley","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2024.155465_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042170","article-title":"Fatty acid metabolism in ovarian cancer: therapeutic implications","volume":"23","author":"Yoon","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155465_bib5","doi-asserted-by":"crossref","first-page":"768","DOI":"10.18632\/oncotarget.28241","article-title":"Targeting lipid metabolism in the treatment of ovarian cancer","volume":"13","author":"Chaudhry","year":"2022","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2024.155465_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101529","article-title":"New dawn for cancer cell death: emerging role of lipid metabolism","volume":"63","author":"Zhang","year":"2022","journal-title":"Mol. Metab."},{"issue":"3","key":"10.1016\/j.prp.2024.155465_bib7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-021-00781-x","article-title":"Diet, lipids, and antitumor immunity","volume":"19","author":"Prendeville","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"24","key":"10.1016\/j.prp.2024.155465_bib8","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.7150\/jca.64833","article-title":"Aberrant lipid metabolism in cancer cells and tumor microenvironment: the player rather than bystander in cancer progression and metastasis","volume":"12","author":"Yu","year":"2021","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2024.155465_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mco2.27","article-title":"Lipid metabolism in cancer progression and therapeutic strategies","volume":"2","author":"Fu","year":"2020","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.prp.2024.155465_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","article-title":"Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer","volume":"31","author":"Snaebjornsson","year":"2020","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.prp.2024.155465_bib11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1158\/2159-8290.CD-12-0345","article-title":"Cancer cell metabolism: one hallmark, many faces","volume":"2","author":"Cantor","year":"2012","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.prp.2024.155465_bib12","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s11745-004-1329-9","article-title":"Structure and function of animal fatty acid synthase","volume":"39","author":"Chirala","year":"2004","journal-title":"Lipids"},{"issue":"5765","key":"10.1016\/j.prp.2024.155465_bib13","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1126\/science.1123248","article-title":"Architecture of mammalian fatty acid synthase at 4.5 A resolution","volume":"311","author":"Maier","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.prp.2024.155465_bib14","article-title":"Amelioration of LPS-induced inflammation response in microglia by AMPK activation","volume":"2014","author":"Chen","year":"2014","journal-title":"BioMed. Res. Int."},{"issue":"6","key":"10.1016\/j.prp.2024.155465_bib15","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1158\/0008-5472.CAN-11-4057","article-title":"Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer","volume":"72","author":"Zaytseva","year":"2012","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.prp.2024.155465_bib16","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/ajg.2009.230","article-title":"High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target","volume":"104","author":"Uddin","year":"2009","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.prp.2024.155465_bib17","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3892\/etm.2013.959","article-title":"Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase","volume":"5","author":"Long","year":"2013","journal-title":"Exp. Ther. Med"},{"issue":"10","key":"10.1016\/j.prp.2024.155465_bib18","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1210\/jc.2008-0503","article-title":"Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers","volume":"93","author":"Uddin","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.prp.2024.155465_bib19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/MCG.0b013e318207f240","article-title":"Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis","volume":"45","author":"Ishimura","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"issue":"34","key":"10.1016\/j.prp.2024.155465_bib20","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1038\/sj.onc.1208555","article-title":"FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis","volume":"24","author":"Bandyopadhyay","year":"2005","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.prp.2024.155465_bib21","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3892\/ol.2012.862","article-title":"Fatty acid synthase expression in osteosarcoma and its correlation with pulmonary metastasis","volume":"4","author":"Liu","year":"2012","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.prp.2024.155465_bib22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12032-014-0391-z","article-title":"Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer","volume":"32","author":"Cai","year":"2015","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2024.155465_bib23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s13277-012-0605-y","article-title":"Fatty acid synthase overexpression confers an independent prognosticator and associates with radiation resistance in nasopharyngeal carcinoma","volume":"34","author":"Kao","year":"2013","journal-title":"Tumour Biol.: J. Int. Soc. Oncodev. Biol. Med."},{"issue":"3","key":"10.1016\/j.prp.2024.155465_bib24","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.juro.2008.04.135","article-title":"Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma","volume":"180","author":"Horiguchi","year":"2008","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.prp.2024.155465_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ijc.24356","article-title":"Increased expression of fatty acid synthase in human aberrant crypt foci: possible target for colorectal cancer prevention","volume":"125","author":"Kearney","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2024.155465_bib26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3892\/ijmm.2013.1602","article-title":"Positive feedback regulation between Akt phosphorylation and fatty acid synthase expression in osteosarcoma","volume":"33","author":"Wang","year":"2014","journal-title":"Int. J. Mol. Med."},{"issue":"7","key":"10.1016\/j.prp.2024.155465_bib27","doi-asserted-by":"crossref","first-page":"11539","DOI":"10.3390\/ijms150711539","article-title":"Up-regulated FASN expression promotes transcoelomic metastasis of ovarian cancer cell through epithelial-mesenchymal transition","volume":"15","author":"Jiang","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2024.155465_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41389-023-00460-8","article-title":"Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies","volume":"12","author":"Vanauberg","year":"2023","journal-title":"Oncogenesis"},{"issue":"11","key":"10.1016\/j.prp.2024.155465_bib29","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat. Med."},{"issue":"24","key":"10.1016\/j.prp.2024.155465_bib30","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1158\/1078-0432.CCR-15-0126","article-title":"Molecular pathways: fatty acid synthase","volume":"21","author":"Jones","year":"2015","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"10","key":"10.1016\/j.prp.2024.155465_bib31","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.prp.2024.155465_bib32","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1080\/01635581.2012.701704","article-title":"Fatty acid synthase regulates proliferation and migration of colorectal cancer cells via HER2-PI3K\/Akt signaling pathway","volume":"64","author":"Li","year":"2012","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.prp.2024.155465_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s42003-019-0508-1","article-title":"Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells","volume":"2","author":"Chen","year":"2019","journal-title":"Commun. Biol."},{"issue":"2","key":"10.1016\/j.prp.2024.155465_bib34","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/bjc.2012.246","article-title":"Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas","volume":"107","author":"Rahman","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.prp.2024.155465_bib35","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1158\/0008-5472.CAN-05-4673","article-title":"Fatty acid synthase and cancer: new application of an old pathway","volume":"66","author":"Kuhajda","year":"2006","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.prp.2024.155465_bib36","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.bjc.6605007","article-title":"De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy","volume":"100","author":"Mashima","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2024.155465_bib37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.humpath.2005.11.022","article-title":"Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma.","volume":"37","author":"Shah","year":"2006","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2024.155465_bib38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1476-4598-8-74","article-title":"Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer","volume":"8","author":"Uddin","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2024.155465_bib39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1746-1596-9-79","article-title":"CD44v\/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients","volume":"9","author":"Li","year":"2014","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.prp.2024.155465_bib40","doi-asserted-by":"crossref","unstructured":"Lawrenson K., Mhawech-Fauceglia P., Worthington J., Spindler T.J., O'Brien D., Lee J.M., et al. Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the Secretomes of three-dimensional genetic models of ovarian carcinogenesis. Int J Cancer. 2014.","DOI":"10.1002\/ijc.29197"},{"issue":"6","key":"10.1016\/j.prp.2024.155465_bib41","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0046-8177(97)90177-5","article-title":"Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival","volume":"28","author":"Gansler","year":"1997","journal-title":"Hum. Pathol."},{"issue":"12","key":"10.1016\/j.prp.2024.155465_bib42","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1101\/gad.1777309","article-title":"The rate of cell growth is governed by cell cycle stage","volume":"23","author":"Goranov","year":"2009","journal-title":"Genes Dev."},{"issue":"29","key":"10.1016\/j.prp.2024.155465_bib43","doi-asserted-by":"crossref","first-page":"10715","DOI":"10.1073\/pnas.0403390101","article-title":"Inhibition of fatty acid synthase (FAS) suppresses HER2\/neu (erbB-2) oncogene overexpression in cancer cells","volume":"101","author":"Menendez","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.prp.2024.155465_bib44","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1158\/0008-5472.CAN-06-3439","article-title":"Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells","volume":"67","author":"Zhou","year":"2007","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2024.155465_bib45","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbrc.2009.05.085","article-title":"Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells","volume":"385","author":"Grunt","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2024.155465_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/285191","article-title":"Expression of fatty acid synthase depends on NAC1 and is associated with recurrent ovarian serous carcinomas","volume":"2010","author":"Ueda","year":"2010","journal-title":"J. Oncol."},{"issue":"7-8","key":"10.1016\/j.prp.2024.155465_bib47","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2119\/molmed.2011.00046","article-title":"Overexpression of fatty acid synthase in Middle Eastern epithelial ovarian carcinoma activates AKT and Its inhibition potentiates cisplatin-induced apoptosis","volume":"17","author":"Uddin","year":"2011","journal-title":"Mol. Med"},{"issue":"9","key":"10.1016\/j.prp.2024.155465_bib48","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1515\/bchm3.1986.367.2.905","article-title":"Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase","volume":"367","author":"Weiss","year":"1986","journal-title":"Biol. Chem. Hoppe Seyler"},{"issue":"7","key":"10.1016\/j.prp.2024.155465_bib49","first-page":"687","article-title":"Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.","volume":"32","author":"Corominas-Faja","year":"2017","journal-title":"Histol. Histopathol."},{"issue":"1","key":"10.1016\/j.prp.2024.155465_bib50","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12967-015-0511-3","article-title":"Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer","volume":"13","author":"Bauerschlag","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prp.2024.155465_bib51","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12967-015-0511-3","article-title":"Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer","volume":"13","author":"Bauerschlag","year":"2015","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.prp.2024.155465_bib52","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/ijc.31392","article-title":"The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model","volume":"143","author":"Papaevangelou","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2024.155465_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2184.2007.00498.x","article-title":"Overexpression of fatty acid synthase gene activates HER1\/HER2 tyrosine kinase receptors in human breast epithelial cells","volume":"41","author":"Vazquez-Martin","year":"2008","journal-title":"Cell Prolif."},{"issue":"12","key":"10.1016\/j.prp.2024.155465_bib54","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1158\/1541-7786.MCR-10-0467","article-title":"Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer","volume":"9","author":"Tomek","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.prp.2024.155465_bib55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semcancer.2015.09.008","article-title":"Involvement of F-BOX proteins in progression and development of human malignancies","volume":"36","author":"Uddin","year":"2016","journal-title":"Semin Cancer Biol."},{"issue":"43","key":"10.1016\/j.prp.2024.155465_bib56","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1038\/sj.onc.1208802","article-title":"PKB\/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP","volume":"24","author":"Porstmann","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.prp.2024.155465_bib57","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/excr.2002.5600","article-title":"Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase","volume":"279","author":"Yang","year":"2002","journal-title":"Exp. Cell Res."},{"issue":"56","key":"10.1016\/j.prp.2024.155465_bib58","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1038\/sj.onc.1207115","article-title":"PI3K\/Akt and apoptosis: size matters","volume":"22","author":"Franke","year":"2003","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.prp.2024.155465_bib59","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0898-6568(01)00271-6","article-title":"The protein kinase B\/Akt signalling pathway in human malignancy","volume":"14","author":"Nicholson","year":"2002","journal-title":"Cell Signal"},{"issue":"9","key":"10.1016\/j.prp.2024.155465_bib60","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1158\/0008-5472.CAN-06-4484","article-title":"Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells","volume":"67","author":"Reichert","year":"2007","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.prp.2024.155465_bib61","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1210\/en.2003-0982","article-title":"Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status","volume":"144","author":"Hardie","year":"2003","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.prp.2024.155465_bib62","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI29044","article-title":"AMP-activated protein kinase signaling in metabolic regulation","volume":"116","author":"Long","year":"2006","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.prp.2024.155465_bib63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tips.2004.12.011","article-title":"AMPK, the metabolic syndrome and cancer","volume":"26","author":"Luo","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"issue":"45","key":"10.1016\/j.prp.2024.155465_bib64","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1038\/sj.onc.1203889","article-title":"Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway","volume":"19","author":"Swinnen","year":"2000","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/j.prp.2024.155465_bib65","doi-asserted-by":"crossref","first-page":"14767","DOI":"10.1074\/jbc.273.24.14767","article-title":"AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes","volume":"273","author":"Foretz","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.prp.2024.155465_bib66","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0014-5793(98)00745-5","article-title":"The 5\u2032-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex","volume":"431","author":"Leclerc","year":"1998","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.prp.2024.155465_bib67","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc2676","article-title":"The LKB1-AMPK pathway: metabolism and growth control in tumour suppression","volume":"9","author":"Shackelford","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2024.155465_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.610885","article-title":"The pharmacological or genetic blockade of endogenous de novo fatty acid synthesis does not increase the uptake of exogenous lipids in ovarian cancer cells","volume":"11","author":"Grunt","year":"2021","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.prp.2024.155465_bib69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41419-019-2221-x","article-title":"SIK2 enhances synthesis of fatty acid and cholesterol in ovarian cancer cells and tumor growth through PI3K\/Akt signaling pathway","volume":"11","author":"Zhao","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2024.155465_bib70","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.3389\/fimmu.2018.02927","article-title":"Ovarian cancer-intrinsic fatty acid synthase prevents anti-tumor immunity by disrupting tumor-infiltrating dendritic cells","volume":"9","author":"Jiang","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.prp.2024.155465_bib71","doi-asserted-by":"crossref","first-page":"11600","DOI":"10.18632\/oncotarget.14591","article-title":"Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells","volume":"8","author":"Wagner","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.prp.2024.155465_bib72","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/ijc.29261","article-title":"Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells","volume":"136","author":"Veigel","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2024.155465_bib73","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000342967","article-title":"Fatty acid synthase is a potential therapeutic target in estrogen receptor-\/progesterone receptor-positive endometrioid endometrial cancer","volume":"84","author":"Rahman","year":"2013","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.prp.2024.155465_bib74","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3892\/ijo.2012.1465","article-title":"Orlistat, a novel potent antitumor agent for ovarian cancer: proteomic analysis of ovarian cancer cells treated with Orlistat","volume":"41","author":"Huang","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2024.155465_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034443","article-title":"Efficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft model","volume":"7","author":"Moore","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.prp.2024.155465_bib76","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol. Cell"},{"issue":"15","key":"10.1016\/j.prp.2024.155465_bib77","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","article-title":"Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling","volume":"17","author":"Inoki","year":"2003","journal-title":"Genes Dev."},{"issue":"46","key":"10.1016\/j.prp.2024.155465_bib78","doi-asserted-by":"crossref","first-page":"31378","DOI":"10.1074\/jbc.M803384200","article-title":"Inhibition of fatty-acid synthase induces caspase-8-mediated tumor cell apoptosis by up-regulating DDIT4","volume":"283","author":"Knowles","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.prp.2024.155465_bib79","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/jcp.24258","article-title":"Mollugin inhibits proliferation and induces apoptosis by suppressing fatty acid synthase in HER2-overexpressing cancer cells","volume":"228","author":"Do","year":"2013","journal-title":"J. Cell Physiol."},{"issue":"3","key":"10.1016\/j.prp.2024.155465_bib80","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2024.5612","article-title":"Targeting endogenous fatty acid synthesis stimulates the migration of ovarian cancer cells to adipocytes and promotes the transport of fatty acids from adipocytes to cancer cells","volume":"64","author":"Grunt","year":"2024","journal-title":"Int. J. Oncol."},{"issue":"22","key":"10.1016\/j.prp.2024.155465_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216503","article-title":"Resensitizing paclitaxel-resistant ovarian cancer via targeting lipid metabolism key enzymes CPT1A, SCD and FASN","volume":"24","author":"Ma","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.prp.2024.155465_bib82","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1158\/2767-9764.CRC-23-0030","article-title":"Targeting fatty acid reprogramming suppresses CARM1-expressing ovarian cancer","volume":"3","author":"Lombardi","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.prp.2024.155465_bib83","article-title":"Fatty acid synthase correlates with prognosis-related abdominal adipose distribution and metabolic disorders of clear cell renal cell carcinoma","volume":"7","author":"Xu","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.prp.2024.155465_bib84","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/ncomms2537","article-title":"De novo lipogenesis in human fat and liver is linked to ChREBP-beta and metabolic health","volume":"4","author":"Eissing","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2024.155465_bib85","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/232946","article-title":"Targeting FASN in breast cancer and the discovery of promising inhibitors from natural products derived from traditional chinese medicine","volume":"2014","author":"Cheng","year":"2014","journal-title":"Evid. Based Complement Altern. Med"},{"issue":"4","key":"10.1016\/j.prp.2024.155465_bib86","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/fon.10.11","article-title":"Fatty acid synthase as a potential therapeutic target in cancer","volume":"6","author":"Flavin","year":"2010","journal-title":"Future Oncol."},{"key":"10.1016\/j.prp.2024.155465_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.676562","article-title":"Aberrant metabolism as inductor of epigenetic changes in breast cancer: therapeutic opportunities","volume":"11","author":"Coronel-Hernandez","year":"2021","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2024.155465_bib88","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1158\/1078-0432.CCR-07-4177","article-title":"Inhibiting fatty acid synthase for chemoprevention of chemically induced lung tumors","volume":"14","author":"Orita","year":"2008","journal-title":"Clin. Cancer Res."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824003765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824003765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T14:24:17Z","timestamp":1735136657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824003765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":88,"alternative-id":["S0344033824003765"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155465","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatty acid synthase: A key driver of ovarian cancer metastasis and a promising therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"155465"}}